Everett Vokes

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Langerman Alexander; Plein Colleen; Vokes Everett E; Salama Joseph K; Haraf Daniel J; Blair Elizabeth A; Stenson Kerstin M
Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Wakelee Heather; Loo Bill W; Kernstine Kemp H; Putnam Joe Bill; Edelman Martin J; Vokes Everett E; Schiller Joan H; Baas Paul; Saijo Nagahiro; Adjei Alex; Goss Glenwood; Choy Hak; Gandara David R
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress.
Cohen Ezra Eddy Wyssam; Halpern Anna B; Kasza Kristen; Kocherginsky Masha; Williams Rosalyn; Vokes Everett E
Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Everett Vokes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Langerman Alexander; Plein Colleen; Vokes Everett E; Salama Joseph K; Haraf Daniel J; Blair Elizabeth A; Stenson Kerstin M
Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Archives of otolaryngology--head & neck surgery 2009;135(11):1133-6.
2009: Wakelee Heather; Loo Bill W; Kernstine Kemp H; Putnam Joe Bill; Edelman Martin J; Vokes Everett E; Schiller Joan H; Baas Paul; Saijo Nagahiro; Adjei Alex; Goss Glenwood; Choy Hak; Gandara David R
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress.
Clinical lung cancer 2009;10(6):395-404.
2009: Cohen Ezra Eddy Wyssam; Halpern Anna B; Kasza Kristen; Kocherginsky Masha; Williams Rosalyn; Vokes Everett E
Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
Oral oncology 2009;45(10):e155-60.
2009: Sangha Randeep; Lara Primo N; Adjei Alex A; Baas Paul; Choy Hak; Gaspar Laurie E; Goss Glenwood; Saijo Nagahiro; Schiller Joan H; Vokes Everett E; Gandara David R
Cooperative group research endeavors in small-cell lung cancer: current and future directions.
Clinical lung cancer 2009;10(5):322-30.
2009: Langerman Alexander; Comstock Richard; Konda Sheela; Abramovitch Anna; Kasza Kristen; Vokes Everett E; Stenson Kerstin M
Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2009;135(9):876-80.
2009: Krishnaswamy Soundararajan; Kanteti Rajani; Duke-Cohan Jonathan S; Loganathan Sivakumar; Liu Wanqing; Ma Patrick C; Sattler Martin; Singleton Patrick A; Ramnath Nithya; Innocenti Federico; Nicolae Dan L; Ouyang Zheng; Liang Jie; Minna John; Kozloff Mark F; Ferguson Mark K; Natarajan Viswanathan; Wang Yi-Ching; Garcia Joe G N; Vokes Everett E; Salgia Ravi
Ethnic differences and functional analysis of MET mutations in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5714-23.
2009: Stinchcombe Thomas E; Hodgson Lydia; Herndon James E; Kelley Michael J; Cicchetti M Giulia; Ramnath Nithya; Niell Harvey B; Atkins James N; Akerley Wallace; Green Mark R; Vokes Everett E;
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(9):1117-25.
2009: Cohen Ezra E W; Baru Joshua; Huo Dezheng; Haraf Daniel J; Crowley Maureen; Witt Mary Ellyn; Blair Elizabeth A; Weichselbaum Ralph R; Rosen Fred; Vokes Everett E; Stenson Kerstin
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Head & neck 2009;31(8):1013-21.
2009: Vokes Everett E; Senan Suresh; Treat Joseph A; Iscoe Neill A
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histology.
Clinical lung cancer 2009;10(3):193-8.
2009: Seiwert Tanguy Y; Jagadeeswaran Ramasamy; Faoro Leonardo; Janamanchi Varalakshmi; Nallasura Vidya; El Dinali Mohamed; Yala Soheil; Kanteti Rajani; Cohen Ezra E W; Lingen Mark W; Martin Leslie; Krishnaswamy Soundararajan; Klein-Szanto Andres; Christensen James G; Vokes Everett E; Salgia Ravi
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Cancer research 2009;69(7):3021-31.
2009: Stewart J Simon W; Cohen Ezra E W; Licitra Lisa; Van Herpen Carla M L; Khorprasert Chonlakiet; Soulieres Denis; Vodvarka Pavel; Rischin Danny; Garin Avgust M; Hirsch Fred R; Varella-Garcia Marileila; Ghiorghiu Serban; Hargreaves Laura; Armour Alison; Speake Georgina; Swaisland Alan; Vokes Everett E
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1864-71.
2009: Kim Edward S; Mauer Ann M; William William N; Tran Hai T; Liu Diane; Lee Jack J; Windt Paul; Hong Waun K; Vokes Everett E; Herbst Roy S
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.
Cancer 2009;115(8):1713-22.
2009: Cohen Ezra E W; Davis Darren W; Karrison Theodore G; Seiwert Tanguy Y; Wong Stuart J; Nattam Sreenivasa; Kozloff Mark F; Clark Joseph I; Yan Duen-Hwa; Liu Wen; Pierce Carolyn; Dancey Janet E; Stenson Kerstin; Blair Elizabeth; Dekker Allison; Vokes Everett E
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
The lancet oncology 2009;10(3):247-57.
2009: Kanteti Rajani; Nallasura Vidya; Loganathan Sivakumar; Tretiakova Maria; Kroll Todd; Krishnaswamy Soundararajan; Faoro Leonardo; Cagle Philip; Husain Aliya N; Vokes Everett E; Lang Deborah; Salgia Ravi
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Laboratory investigation; a journal of technical methods and pathology 2009;89(3):301-14.
2009: Govindan Ramaswamy; Wang Xiaofei; Baggstrom Maria Q; Burdette-Radoux Susan; Hodgson Lydia; Vokes Everett E; Green Mark R;
A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(2):220-6.
2009: Brizel David M; Vokes Everett E
Induction chemotherapy: to use or not to use? That is the question.
Seminars in radiation oncology 2009;19(1):11-6.
2008: Kindler Hedy Lee; Aklilu Mebea; Nattam Sreenivasa; Vokes Everett E
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
American journal of clinical oncology 2008;31(6):553-6.
2008: Ma Patrick C; Tretiakova Maria S; MacKinnon Alexander C; Ramnath Nithya; Johnson Candace; Dietrich Sascha; Seiwert Tanguy; Christensen James G; Jagadeeswaran Ramasamy; Krausz Thomas; Vokes Everett E; Husain Aliya N; Salgia Ravi
Expression and mutational analysis of MET in human solid cancers.
Genes, chromosomes & cancer 2008;47(12):1025-37.
2008: Stinchcombe Thomas E; Mauer Ann M; Hodgson Lydia D; Herndon James E; Lynch Thomas J; Green Mark R; Vokes Everett E;
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(11):1301-7.
2008: Strauss Gary M; Herndon James E; Maddaus Michael A; Johnstone David W; Johnson Elizabeth A; Harpole David H; Gillenwater Heidi H; Watson Dorothy M; Sugarbaker David J; Schilsky Richard L; Vokes Everett E; Green Mark R
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5043-51.
2008: Salama Joseph K; Stenson Kerstin M; List Marcy A; Mell Loren K; Maccracken Ellen; Cohen Ezra E; Blair Elizabeth; Vokes Everett E; Haraf Daniel J
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2008;134(10):1060-5.
2008: Miller Antonius A; Wang Xiaofei F; Gu Lin; Hoffman Philip; Khatri Jamil; Dunphy Frank; Edelman Martin J; Bolger Michael; Vokes Everett E; Green Mark R;
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(10):1159-65.
2008: Faoro Leonardo; Loganathan Sivakumar; Westerhoff Maria; Modi Rahul; Husain Aliya N; Tretiakova Maria; Seiwert Tanguy; Kindler Hedy L; Vokes Everett E; Salgia Ravi
Protein kinase C beta in malignant pleural mesothelioma.
Anti-cancer drugs 2008;19(9):841-8.
2008: Cohen Ezra E W; Rosen Lee S; Vokes Everett E; Kies Merrill S; Forastiere Arlene A; Worden Francis P; Kane Madeleine A; Sherman Eric; Kim Sinil; Bycott Paul; Tortorici Michael; Shalinsky David R; Liau Katherine F; Cohen Roger B
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4708-13.
2008: Salama J K; Stenson K M; Kistner E O; Mittal B B; Argiris A; Witt M E; Rosen F; Brockstein B E; Cohen E E W; Haraf D J; Vokes E E
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1787-94.
2008: Choong Nicholas W; Mauer Ann M; Haraf Daniel J; Lester Eric; Hoffman Philip C; Kozloff Mark; Lin Shang; Dancey Janet E; Szeto Livia; Grushko Tatyana; Olopade Olufunmilayo I; Salgia Ravi; Vokes Everett E
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(9):1003-11.
2008: Knab B R; Salama J K; Solanki A; Stenson K M; Cohen E E; Witt M E; Haraf D J; Vokes E E
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(9):1650-4.
2008: Salama Joseph K; Chmura Steven J; Mehta Neil; Yenice Kamil M; Stadler Walter M; Vokes Everett E; Haraf Daniel J; Hellman Samuel; Weichselbaum Ralph R
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5255-9.
2008: Govindan Ramaswamy; Bogart Jeffrey; Vokes Everett E
Locally advanced non-small cell lung cancer: the past, present, and future.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(8):917-28.
2008: Cohn Alvin B; Lang Patrick O; Agarwal Jayant P; Peng Stephanie L; Alizadeh Kaveh; Stenson Kerstin M; Haraf Daniel J; Cohen Ezra E W; Vokes Everett E; Gottlieb Lawrence J
Free-flap reconstruction in the doubly irradiated patient population.
Plastic and reconstructive surgery 2008;122(1):125-32.
2008: Nimeiri Halla S; Oza Amit M; Morgan Robert J; Friberg Gregory; Kasza Kristen; Faoro Leonardo; Salgia Ravi; Stadler Walter M; Vokes Everett E; Fleming Gini F;
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Gynecologic oncology 2008;110(1):49-55.
2008: Salama Joseph K; Vokes Everett E
Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
Seminars in oncology 2008;35(3):251-61.
2008: Vokes Everett E; Cohen Ezra E W; Grandis Jennifer R
Introduction: head and neck cancer.
Seminars in oncology 2008;35(3):196-7.
2008: Socinski Mark A; Blackstock A William; Bogart Jeffrey A; Wang Xiaofei; Munley Michael; Rosenman Julian; Gu Lin; Masters Gregory A; Ungaro Peter; Sleeper Arthur; Green Mark; Miller Antonius A; Vokes Everett E
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2457-63.
2008: Kratzke Robert A; Wang Xiaofei; Wong Long; Kratzke Marian G; Green Mark R; Vokes Everett E; Vogelzang Nicholas J; Kindler Hedy L; Kern Jeffrey A;
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(4):417-21.
2008: Seiwert Tanguy Y; Haraf Daniel J; Cohen Ezra E W; Stenson Kerstin; Witt Mary Ellyn; Dekker Allison; Kocherginsky Masha; Weichselbaum Ralph R; Chen Helen X; Vokes Everett E
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1732-41.
2008: Langer Corey J; Wakelee Heather; Schiller Joan; Choy Hak; Shepherd Frances; Vokes Everett E; Adjei Alex A; Baas Paul; Saijo Nagahiro; Gandara David R
Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?
Clinical lung cancer 2008;9(2):85-91.
2008: Vokes Everett E
Combining radiotherapy with systemic therapies.
Clinical advances in hematology & oncology : H&O 2008;6(3):167-9.
2008: Rudin Charles M; Liu Wanqing; Desai Apurva; Karrison Theodore; Jiang Xuemin; Janisch Linda; Das Soma; Ramirez Jacqueline; Poonkuzhali Balasubramanian; Schuetz Erin; Fackenthal Donna Lee; Chen Peixian; Armstrong Deborah K; Brahmer Julie R; Fleming Gini F; Vokes Everett E; Carducci Michael A; Ratain Mark J
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1119-27.
2008: Rudin Charles M; Salgia Ravi; Wang Xiaofei; Hodgson Lydia D; Masters Gregory A; Green Mark; Vokes Everett E
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):870-6.
2008: Edelman Martin J; Watson Dee; Wang Xiaofei; Morrison Carl; Kratzke Robert A; Jewell Scott; Hodgson Lydia; Mauer Ann M; Gajra Ajeet; Masters Gregory A; Bedor Michelle; Vokes Everett E; Green Mark J
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):848-55.
2008: Choong Nicholas W; Vokes Everett E; Haraf Daniel J; Tothy Peter K; Ferguson Mark K; Kasza Kristen; Rudin Charles M; Hoffman Philip C; Krauss Stuart A; Szeto Livia; Mauer Ann M
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(1):59-67.
2008: Choong Nicholas; Vokes Everett
Expanding role of the medical oncologist in the management of head and neck cancer.
CA: a cancer journal for clinicians 2008;58(1):32-53.
2007: Langerman Alexander; Maccracken Ellen; Kasza Kristen; Haraf Daniel J; Vokes Everett E; Stenson Kerstin M
Aspiration in chemoradiated patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2007;133(12):1289-95.
2007: Yount Susan; List Marcy; Du Hongyan; Yost Kathleen; Bode Rita; Brockstein Bruce; Argiris Athanassios; Vokes Everett; Cohen Ezra E W; Campbell Bruce; Valenzuela Veronica; George Jacquelyn; Egan Robyn; Chen Jessica; Meddis David; Cella David
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(10):1615-26.
2007: Weiss Glen J; Vokes Everett E; Bunn Paul A; Magree Lyn; Rusk Jason; Albert Don; Kelly Karen
Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):933-8.
2007: Seiwert Tanguy Y; Cohen Ezra E W; Haraf Daniel J; Stenson Kerstin; Blair Elizabeth A; Mauer Ann; Dekker Allison; Vokes Everett E
A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Cancer investigation 2007;25(6):435-44.
2007: Salama Joseph K; Seiwert Tanguy Y; Vokes Everett E
Chemoradiotherapy for locally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4118-26.
2007: Agulnik Mark; Cohen Ezra W E; Cohen Roger B; Chen Eric X; Vokes Everett E; Hotte Sebastien J; Winquist Eric; Laurie Scott; Hayes D Neil; Dancey Janet E; Brown Shirley; Pond Gregory R; Lorimer Ian; Daneshmand Manijeh; Ho James; Tsao Ming-Sound; Siu Lillian L
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3978-84.
2007: Miller Antonius A; Wang Xiaofei F; Bogart Jeffrey A; Hodgson Lydia D; Rocha Lima Caio M S; Radford James E; Vokes Everett E; Green Mark R;
Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(7):645-51.
2007: Lazarus Cathy; Logemann Jeri A; Pauloski Barbara Roa; Rademaker Alfred W; Helenowski Irene B; Vonesh Edward F; Maccracken Ellen; Mittal Bharat B; Vokes Everett E; Haraf Daniel J
Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.
Head & neck 2007;29(7):632-7.
2007: Vokes Everett E; Herndon James E; Kelley Michael J; Cicchetti M Giulia; Ramnath Nithya; Neill Harvey; Atkins James N; Watson Dorothy M; Akerley Wallace; Green Mark R;
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1698-704.
2007: Posadas Edwin M; Undevia Samir; Manchen Elizabeth; Wade James L; Colevas A Dimitrios; Karrison Theodore; Vokes Everett E; Stadler Walter M
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Cancer biology & therapy 2007;6(4):490-3.
2007: Seiwert Tanguy Y; Salama Joseph K; Vokes Everett E
The chemoradiation paradigm in head and neck cancer.
Nature clinical practice. Oncology 2007;4(3):156-71.
2007: Cohen Ezra E W; Rosine Dominique; Haraf Daniel J; Loh Elwyn; Shen Liji; Lusinchi Antoine; Vokes Everett E; Bourhis Jean
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
International journal of radiation oncology, biology, physics 2007;67(3):678-84.
2007: Choong Nicholas W; Salgia Ravi; Vokes Everett E
Key signaling pathways and targets in lung cancer therapy.
Clinical lung cancer 2007;8 Suppl 2():S52-60.
2007: Seiwert Tanguy Y; Salama Joseph K; Vokes Everett E
The concurrent chemoradiation paradigm--general principles.
Nature clinical practice. Oncology 2007;4(2):86-100.
2007: Perry Michael C; Kohman Leslie J; Bonner James A; Gu Lin; Wang Xiaofei; Vokes Everett E; Green Mark R
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.
Clinical lung cancer 2007;8(4):268-72.
2007: Seiwert Tanguy Y; Connell Philip P; Mauer Ann M; Hoffman Philip C; George Christopher M; Szeto Livia; Salgia Ravi; Posther Katherine E; Nguyen Binh; Haraf Daniel J; Vokes Everett E
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):515-22.
2007: Harari Paul M; Cohen Roger B; Raben David; Myers Jeffrey N; Vokes Everett E; Weber Randal S; Ang K Kian
The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium.
International journal of radiation oncology, biology, physics 2007;69(2 Suppl):S1-3.
2006: Vokes Everett; Herbst Roy; Sandler Alan
Angiogenesis inhibition in the treatment of lung cancer.
Clinical advances in hematology & oncology : H&O 2006;4(11 Suppl 23):1-10; quiz 11-2.
2006: Ryan Christopher W; Dolan M Eileen; Brockstein Bruce B; McLendon Roger; Delaney Shannon M; Samuels Brian L; Agamah Edem S; Vokes Everett E
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
Cancer chemotherapy and pharmacology 2006;58(5):634-9.
2006: Cohen Ezra E W; Haraf Daniel J; List Marcy A; Kocherginsky Masha; Mittal Bharat B; Rosen Fred; Brockstein Bruce; Williams Rosalyn; Witt Mary Ellyn; Stenson Kerstin M; Kies Merrill S; Vokes Everett E
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3438-44.
2006: Argiris Athanassios; Cohen Ezra; Karrison Theodore; Esparaz Benjamin; Mauer Ann; Ansari Rafat; Wong Stuart; Lu Yi; Pins Michael; Dancey Janet; Vokes Everett
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Cancer biology & therapy 2006;5(7):766-70.
2006: Vokes Everett E; Perry Michael C; Kindler Hedy L; Green Mark R
The cancer and leukemia group B respiratory committee.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3581s-8s.
2006: Innocenti Federico; Vokes Everett E; Ratain Mark J
Irinogenetics: what is the right star?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2221-4.
2006: Milano Michael T; Vokes Everett E; Kao Johnny; Jackson Wells; List Marcy A; Stenson Kerstin M; Witt Mary Ellyn; Dekker Allison; MacCracken Ellen; Garofalo Michael C; Chmura Steven J; Weichselbaum Ralph R; Haraf Daniel J
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
International journal of oncology 2006;28(5):1141-51.
2006: Connell Philip P; Jayathilaka Krishanthi; Haraf Daniel J; Weichselbaum Ralph R; Vokes Everett E; Lingen Mark W
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
International journal of oncology 2006;28(5):1113-9.
2006: Vokes Everett E; Chu Edward
Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.
Oncology (Williston Park, N.Y.) 2006;20(5 Suppl 2):15-25.
2006: Khuri Fadlo R; Lee J Jack; Lippman Scott M; Kim Edward S; Cooper Jay S; Benner Steven E; Winn Rodger; Pajak Thomas F; Williams Brendell; Shenouda George; Hodson Ian; Fu Karen; Shin Dong M; Vokes Everett E; Feng Lei; Goepfert Helmuth; Hong Waun Ki
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Journal of the National Cancer Institute 2006;98(7):441-50.
2006: Choong Nicholas W; Mauer Ann M; Hoffman Philip C; Rudin Charles M; Winegarden Jerome D; Villano J Lee; Kozloff Mark; Wade James L; Sciortino David F; Szeto Livia; Vokes Everett E
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(3):245-51.
2006: Lara Primo N; Stadler Walter M; Longmate Jeff; Quinn David I; Wexler Jason; Van Loan Marta; Twardowski Przemyslaw; Gumerlock Paul H; Vogelzang Nicholas J; Vokes Everett E; Lenz Heinz Josef; Doroshow James H; Gandara David R
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1556-63.
2006: Peterson Amy C; Harlin Helena; Karrison Theodore; Vogelzang Nicholas J; Knost James A; Kugler John W; Lester Eric; Vokes Everett; Gajewski Thomas F; Stadler Walter M;
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Investigational new drugs 2006;24(2):141-9.
2006: Salama Joseph K; Vokes Everett E; Chmura Steven J; Milano Michael T; Kao Johnny; Stenson Kirsten M; Witt Mary Ellyn; Haraf Daniel J
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
International journal of radiation oncology, biology, physics 2006;64(2):382-91.
2006: Blackstock A William; Herndon James E; Paskett Electra D; Miller Antonius A; Lathan Christopher; Niell Harvey B; Socinski Mark A; Vokes Everett E; Green Mark R;
Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):407-12.
2006: Herbst Roy S; Bajorin Dean F; Bleiberg Harry; Blum Diane; Hao Desirée; Johnson Bruce E; Ozols Robert F; Demetri George D; Ganz Patricia A; Kris Mark G; Levin Bernard; Markman Maurie; Raghavan Derek; Reaman Gregory H; Sawaya Raymond; Schuchter Lynn M; Sweetenham John W; Vahdat Linda T; Vokes Everett E; Winn Rodger J; Mayer Robert J;
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):190-205.
2006: Logemann Jeri A; Rademaker Alfred W; Pauloski Barbara Roa; Lazarus Cathy L; Mittal Bharat B; Brockstein Bruce; MacCracken Ellen; Haraf Daniel J; Vokes Everett E; Newman Lisa A; Liu Dachao
Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation.
Head & neck 2006;28(1):64-73.
2005: Choong Nicholas W; Vokes Everett E
Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer.
Clinical lung cancer 2005;7 Suppl 3():S98-104.
2005: Cohen Ezra E W; Kane Madeleine A; List Marcy A; Brockstein Bruce E; Mehrotra Bhoomi; Huo Dezheng; Mauer Ann M; Pierce Carolyn; Dekker Allison; Vokes Everett E
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8418-24.
2005: Cohen Ezra E W; Lingen Mark W; Martin Leslie E; Harris Patricia L; Brannigan Brian W; Haserlat Sara M; Okimoto Ross A; Sgroi Dennis C; Dahiya Sonika; Muir Beth; Clark John R; Rocco James W; Vokes Everett E; Haber Daniel A; Bell Daphne W
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8105-8.
2005: Gajewski Thomas F; Sosman Jeffrey; Gerson Stanton L; Liu Lili; Dolan Eileen; Lin Shang; Vokes Everett E
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7861-5.
2005: Kindler Hedy L; Friberg Gregory; Singh Deepti A; Locker Gershon; Nattam Sreenivasa; Kozloff Mark; Taber David A; Karrison Theodore; Dachman Abraham; Stadler Walter M; Vokes Everett E
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8033-40.
2005: Vokes Everett
Seeking improved outcome in the curative treatment of non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2005;50 Suppl 1():S20-2.
2005: Pasche Boris; Knobloch Thomas J; Bian Yansong; Liu Junjian; Phukan Sharbani; Rosman Diana; Kaklamani Virginia; Baddi Lisa; Siddiqui Farida S; Frankel Wendy; Prior Thomas W; Schuller David E; Agrawal Amit; Lang Jas; Dolan M Eileen; Vokes Everett E; Lane William S; Huang Chiang-Ching; Caldes Trinidad; Di Cristofano Antonio; Hampel Heather; Nilsson IngMarie; von Heijne Gunnar; Fodde Riccardo; Murty V V V S; de la Chapelle Albert; Weghorst Christopher M
Somatic acquisition and signaling of TGFBR1*6A in cancer.
JAMA : the journal of the American Medical Association 2005;294(13):1634-46.
2005: Kindler Hedy L; Tothy Peter K; Wolff Robert; McCormack Richard A; Abbruzzese James L; Mani Sridhar; Wade-Oliver Kurombi T; Vokes Everett E
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers.
Investigational new drugs 2005;23(5):489-93.
2005: Desai Apurva A; Kindler Hedy L; Taber David; Agamah Edem; Mani Sridhar; Wade-Oliver Kurombi; Ratain Mark J; Vokes Everett E
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
Cancer chemotherapy and pharmacology 2005;56(4):421-6.
2005: Vokes Everett E
Optimal therapy for unresectable stage III non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5853-5.
2005: Kindler Hedy Lee; Friberg Gregory; Skoog Linda; Wade-Oliver Kurombi; Vokes Everett E
Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer.
American journal of clinical oncology 2005;28(4):340-4.
2005: Herbst Roy S; Arquette Matthew; Shin Dong M; Dicke Karel; Vokes Everett E; Azarnia Nozar; Hong Waun Ki; Kies Merrill S
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5578-87.
2005: Mauer A M; Kraut E H; Krauss S A; Ansari R H; Kasza K; Szeto L; Vokes E E
Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1320-5.
2005: Akerley Wallace; Herndon James E; Lyss Alan P; Choy Hak; Turrisi Andrew; Graziano Stephen; Williams Todd; Zhang Chunfeng; Vokes Everett E; Green Mark R
Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.
Clinical lung cancer 2005;7(1):47-53.
2005: Vokes Everett E; Crawford Jeffrey; Bogart Jeffrey; Socinski Mark A; Clamon Gerald; Green Mark R
Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):5045s-5050s.
2005: Lynch Thomas J; Bogart Jeffrey A; Curran Walter J; DeCamp Malcolm M; Gandara David R; Goss Glenwood; Henschke Claudia I; Jett James R; Johnson Bruce E; Kelly Karen L; Le Chevalier Thierry; Mulshine James L; Scagliotti Giorgio V; Schiller Joan H; Shaw Alice; Thatcher Nick; Vokes Everett E; Wood Douglas E; Hart Carol
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):4981s-4983s.
2005: Niell Harvey B; Herndon James E; Miller Antonius A; Watson Dorothy M; Sandler Alan B; Kelly Karen; Marks Randolph S; Perry Micheal C; Ansari Rafat H; Otterson Grefory; Ellerton John; Vokes Everett E; Green Mark R;
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3752-9.
2005: Winquist Eric; Vokes Everett; Moore Malcolm J; Schumm L Philip; Hoving Kristin; Stadler Walter M
A Phase II study of oxaliplatin in urothelial cancer.
Urologic oncology 2005;23(3):150-4.
2005: Salama Joseph K; Haraf Daniel J; Stenson Kerstin; Milano Michael T; Witt Mary Ellyn; Vokes Everett E
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Cancer journal (Sudbury, Mass.) 2005;11(2):140-6.
2005: Milano Michael T; Vokes Everett E; Salama Joseph K; Stenson Kerstin M; Kao Johnny; Witt Mary-Ellyn; Mittal Bharat B; Argiris Athanassios; Weichselbaum Ralph R; Haraf Daniel J
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
International journal of radiation oncology, biology, physics 2005;61(4):1096-106.
2005: Hotte Sébastien J; Winquist Eric W; Lamont Elizabeth; MacKenzie Mary; Vokes Everett; Chen Eric X; Brown Shirley; Pond Gregory R; Murgo Anthony; Siu Lillian L
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):585-90.
2005: Vokes E
Current treatments and promising investigations in a multidisciplinary setting.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 6():vi25-vi30.
2004: Brockstein Bruce; Vokes Everett E
Concurrent chemoradiotherapy for head and neck cancer.
Seminars in oncology 2004;31(6):786-93.
2004: Vokes Everett E; Lingen Mark W
Update in head and neck oncology.
Seminars in oncology 2004;31(6):717.
2004: Mehta Neil; Mauer Ann M; Hellman Samuel; Haraf Daniel J; Cohen Ezra E W; Vokes Everett E; Weichselbaum Ralph R
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
International journal of oncology 2004;25(6):1677-83.
2004: Milano Michael T; Haraf Daniel J; Stenson Kerstin M; Witt Mary Ellyn; Eng Cathy; Mittal Bharat B; Argiris Athanassios; Pelzer Harold; Kozloff Mark F; Vokes Everett E
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):4922-32.
2004: Brockstein B; Haraf D J; Rademaker A W; Kies M S; Stenson K M; Rosen F; Mittal B B; Pelzer H; Fung B B; Witt M-E; Wenig B; Portugal L; Weichselbaum R W; Vokes E E
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1179-86.
2004: Kindler Hedy L; Avadhani Anjali; Wade-Oliver Kurombi; Karrison Theodore; Mani Sridhar; Vokes Everett E
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium.
Investigational new drugs 2004;22(3):323-7.
2004: Benson Al B; Ajani Jaffer A; Catalano Robert B; Engelking Constance; Kornblau Steven M; Martenson James A; McCallum Richard; Mitchell Edith P; O'Dorisio Thomas M; Vokes Everett E; Wadler Scott
Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2918-26.
2004: Garden A S; Harris J; Vokes E E; Forastiere A A; Ridge J A; Jones C; Horwitz E M; Glisson B S; Nabell L; Cooper J S; Demas W; Gore E
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2856-64.
2004: Ryan Christopher W; Vogelzang Nicholas J; Vokes Everett E; Kindler Hedy L; Undevia Samir D; Humerickhouse Rod; André Amy K; Wang Qiang; Carr Robert A; Ratain Mark J
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4406-11.
2004: Medved Milica; Karczmar Greg; Yang Cheng; Dignam James; Gajewski Thomas F; Kindler Hedy; Vokes Everett; MacEneany Peter; Mitchell Myrosia T; Stadler Walter M
Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.
Journal of magnetic resonance imaging : JMRI 2004;20(1):122-8.
2004: Socinski M A; Zhang C; Herndon J E; Dillman R O; Clamon G; Vokes E; Akerley W; Crawford J; Perry M C; Seagren S L; Green M R
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1033-41.
2004: Eng C; Kindler H L; Nattam S; Ansari R H; Kasza K; Wade-Oliver K; Vokes E E
A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):928-32.
2004: Winegarden J D; Mauer A M; Otterson G A; Rudin C M; Villalona-Calero M A; Lanzotti V J; Szeto L; Kasza K; Hoffman P C; Vokes E E;
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):915-20.
2004: Stadler Walter M; Cao Dingcai; Vogelzang Nicholas J; Ryan Christopher W; Hoving Kristin; Wright Russell; Karrison Theodore; Vokes Everett E
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3365-70.
2004: Argiris Athanassios; Stenson Kerstin M; Brockstein Bruce E; Mittal Bharat B; Pelzer Harold; Kies Merrill S; Jayaram Prathima; Portugal Louis; Wenig Barry L; Rosen Fred R; Haraf Daniel J; Vokes Everett E
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Head & neck 2004;26(5):447-55.
2004: Cohen Ezra E W; Lingen Mark W; Vokes Everett E
The expanding role of systemic therapy in head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1743-52.
2004: Innocenti Federico; Undevia Samir D; Iyer Lalitha; Chen Pei Xian; Das Soma; Kocherginsky Masha; Karrison Theodore; Janisch Linda; Ramírez Jacqueline; Rudin Charles M; Vokes Everett E; Ratain Mark J
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1382-8.
2004: Argiris Athanassios; Brockstein Bruce E; Haraf Daniel J; Stenson Kerstin M; Mittal Bharat B; Kies Merrill S; Rosen Fred R; Jovanovic Borko; Vokes Everett E
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1956-62.
2004: Rudin Charles M; Kozloff Mark; Hoffman Philip C; Edelman Martin J; Karnauskas Robyn; Tomek Ronald; Szeto Livia; Vokes Everett E
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1110-7.
2004: Cohen Ezra E W; Vokes Everett E
Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
Hematology/oncology clinics of North America 2004;18(1):81-90.
2004: Kim Edward S; Vokes Everett E; Kies Merrill S
Cetuximab in cancers of the lung and head & neck.
Seminars in oncology 2004;31(1 Suppl 1):61-7.
2004: List Marcy A; Rutherford Judith Lee; Stracks John; Pauloski Barbara Roa; Logemann Jerilyn A; Lundy Donna; Sullivan Paula; Goodwin William; Kies Merrill; Vokes Everett E
Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients.
Head & neck 2004;26(2):163-70.
2004: Davis Nancy B; Taber David A; Ansari Rafat H; Ryan Christopher W; George Christopher; Vokes Everett E; Vogelzang Nicholas J; Stadler Walter M
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):115-9.
2004: Soulieres Denis; Senzer Neil N; Vokes Everett E; Hidalgo Manuel; Agarwala Sanjiv S; Siu Lillian L
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):77-85.
2004: Vogelzang Nicholas J; Karrison Theodore; Stadler Walter M; Garcia Juan; Cohn Helene; Kugler John; Troeger Thomas; Giannone Leonard; Arrieta Rose; Ratain Mark J; Vokes Everett E
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
Cancer 2004;100(1):65-71.
2003: Haraf Daniel J; Rosen Fred R; Stenson Kerstin; Argiris Athanassios; Mittal Bharat B; Witt Mary Ellyn; Brockstein Bruce E; List Marcy A; Portugal Louis; Pelzer Harold; Weichselbaum Ralph R; Vokes Everett E
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5936-43.
2003: Mittal Bharat B; Pauloski Barbara R; Haraf Daniel J; Pelzer Harold J; Argiris Athanassios; Vokes Everett E; Rademaker Alfred; Logemann Jerilyn A
Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.
International journal of radiation oncology, biology, physics 2003;57(5):1219-30.
2003: Ready Neal E; Vokes Everett E
Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;42 Suppl 1():S65-9.
2003: Rudin Charles M; Cohen Ezra E W; Papadimitrakopoulou Vassiliki A; Silverman Sol; Recant Wendy; El-Naggar Adel K; Stenson Kirsten; Lippman Scott M; Hong Waun Ki; Vokes Everett E
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4546-52.
2003: Vokes Everett E; Stenson Kerstin M
Therapeutic options for laryngeal cancer.
The New England journal of medicine 2003;349(22):2087-9.
2003: Lamont Elizabeth B; Hayreh Davinder; Pickett Kate E; Dignam James J; List Marcy A; Stenson Kerstin M; Haraf Daniel J; Brockstein Bruce E; Sellergren Sarah A; Vokes Everett E
Is patient travel distance associated with survival on phase II clinical trials in oncology?
Journal of the National Cancer Institute 2003;95(18):1370-5.
2003: Aklilu M; Kindler H L; Donehower R C; Mani S; Vokes E E
Phase II study of flavopiridol in patients with advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1270-3.
2003: Vokes Everett E; Choy Hak
Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S115-21.
2003: Cohen Ezra E W; Rosen Fred; Stadler Walter M; Recant Wendy; Stenson Kerstin; Huo Dezheng; Vokes Everett E
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(10):1980-7.
2003: Rosen Fred R; Haraf Daniel J; Kies Merrill S; Stenson Kerstin; Portugal Louis; List Marcy A; Brockstein Bruce E; Mittal Bharat B; Rademaker Alfred W; Witt Mary Ellyn; Pelzer Harold; Weichselbaum Ralph R; Vokes Everett E
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1689-97.
2003: Adjei Alex A; Mauer Ann; Bruzek Laura; Marks Randolph S; Hillman Shauna; Geyer Susan; Hanson Lorelei J; Wright John J; Erlichman Charles; Kaufmann Scott H; Vokes Everett E
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1760-6.
2003: Mauer A M; Ansari R H; Hoffman P C; Krauss S A; Taber D; Tembe S A; Gabrys G T; Cotter T; Schumm L P; Szeto L; Vokes E E
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(5):722-8.
2003: Villano J L; Mauer A M; Vokes E E
A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):656-8.
2003: Oh J L; Vokes E E; Kies M S; Mittal B B; Witt M E; Weichselbaum R R; Haraf D J
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):564-9.
2003: Winegarden Jerome D; Mauer Ann M; Gajewski Thomas F; Hoffman Philip C; Krauss Stuart; Rudin Charles M; Vokes Everett E
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;39(2):191-6.
2003: Vokes Everett E; Stenson Kerstin; Rosen Fred R; Kies Merrill S; Rademaker Alfred W; Witt Mary Ellyn; Brockstein Bruce E; List Marcy A; Fung Bing Bing; Portugal Louis; Mittal Bharat B; Pelzer Harold; Weichselbaum Ralph R; Haraf Daniel J
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):320-6.
2003: Argiris Athanassios; Haraf Daniel J; Kies Merrill S; Vokes Everett E
Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
The oncologist 2003;8(4):350-60.
2002: Vokes Everett E; Choy Hak; Gandara David; Mattson Karin
Adjuvant and neoadjuvant treatments for NSCLC.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 4():29-35.
2002: Vokes Everett E; Herndon James E; Crawford Jeffrey; Leopold Kenneth A; Perry Michael C; Miller Antonius A; Green Mark R
Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(20):4191-8.
2002: Hoffman Philip C; Cohen Ezra E W; Masters Gregory A; Haraf Daniel J; Mauer Ann M; Rudin Charles M; Krauss Stuart A; Huo Dezheng; Vokes Everett E
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):65-71.
2002: Vilano J Lee; List Marcy A; Vokes Everett E
The importance of quality-of-life measurements in oncology.
Clinical lung cancer 2002;4(2):110.
2002: Rosen Fred; Vokes Everett E
Curative treatment for advanced head and neck cancer in the community: has the time come?
Cancer journal (Sudbury, Mass.) 2002;8(4):298-300.
2002: List Marcy A; Lee Rutherford Judith; Stracks John; Haraf Daniel; Kies Merrill S; Vokes Everett E
An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.
Cancer 2002;95(1):98-104.
2002: Ryan Christopher W; Vokes Everett E; Vogelzang Nicholas J; Janisch Linda; Kobayashi Ken; Ratain Mark J
A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer.
Cancer chemotherapy and pharmacology 2002;50(1):1-5.
2002: Vokes Everett E; Charoentum Chaiyut; Gordon Gary S; Rudin Charles M; Krauss Stuart A; Hoffman Philip C; Mauer Ann M; Lee Susie; Watson Sylvia
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer.
Clinical lung cancer 2002;3(4):265-70.
2002: Rudin C M; Otterson G A; Mauer A M; Villalona-Calero M A; Tomek R; Prange B; George C M; Szeto L; Vokes E E
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):539-45.
2002: Goh B C; Vokes E E; Joshi A; Ratain M J
Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours.
British journal of cancer 2002;86(4):534-9.
2002: Cohen Ezra E W; Vokes Everett E
Searching for a standard.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):359-61.
2002: Iyer L; Das S; Janisch L; Wen M; Ramírez J; Karrison T; Fleming G F; Vokes E E; Schilsky R L; Ratain M J
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.
The pharmacogenomics journal 2002;2(1):43-7.
2001: Mauceri H J; Seetharam S; Salloum R M; Vokes E E; Weichselbaum R R
Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation.
International journal of oncology 2001;19(4):833-5.
2001: Cohen E E; Vokes E E
Esophageal cancer therapy: a decade of inertia.
Cancer journal (Sudbury, Mass.) 2001;7(5):369-71.
2001: Khuri F R; Kim E S; Lee J J; Winn R J; Benner S E; Lippman S M; Fu K K; Cooper J S; Vokes E E; Chamberlain R M; Williams B; Pajak T F; Goepfert H; Hong W K
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(8):823-9.
2001: Lamont E B; Vokes E E
Chemotherapy in the management of squamous-cell carcinoma of the head and neck.
The lancet oncology 2001;2(5):261-9.
2001: Lippman S M; Lee J J; Karp D D; Vokes E E; Benner S E; Goodman G E; Khuri F R; Marks R; Winn R J; Fry W; Graziano S L; Gandara D R; Okawara G; Woodhouse C L; Williams B; Perez C; Kim H W; Lotan R; Roth J A; Hong W K
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
Journal of the National Cancer Institute 2001;93(8):605-18.
2001: Kies M S; Haraf D J; Rosen F; Stenson K; List M; Brockstein B; Chung T; Mittal B B; Pelzer H; Portugal L; Rademaker A; Weichselbaum R; Vokes E E
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1961-9.
2001: Mantz C A; Vokes E E; Kies M S; Mittal B; Witt M E; List M A; Weichselbaum R R; Haraf D J
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):343-7.
2001: Mantz C A; Vokes E E; Stenson K; Kies M S; Mittal B; Witt M E; List M A; Weichselbaum R R; Haraf D J
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Cancer journal (Sudbury, Mass.) 2001;7(2):140-8.
2001: Cohen E E; Vokes E E
Locally advanced non-small cell lung cancer.
Current treatment options in oncology 2001;2(1):27-42.
2001: Kies M S; Bennett C L; Vokes E E
Locally advanced head and neck cancer.
Current treatment options in oncology 2001;2(1):7-13.
2001: Vokes E E; Gordon G S; Rudin C M; Mauer A M; Watson S; Krauss S; Arrieta R; Golomb H M; Hoffman P C
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.
Investigational new drugs 2001;19(4):329-33.
2001: George C M; Haraf D J; Mauer A M; Krauss S A; Hoffman P C; Rudin C M; Szeto L; Vokes E E
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest.
Investigational new drugs 2001;19(4):303-10.
2001: Brockstein B; Samuels B; Humerickhouse R; Arietta R; Fishkin P; Wade J; Sosman J; Vokes E E
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer.
Investigational new drugs 2001;19(3):249-54.
2001: Vokes E E
Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer.
The oncologist 2001;6 Suppl 1():25-7.
2000: Vokes E E; Gordon G S; Mauer A M; Rudin C M; Krauss S A; Szeto L; Golomb H M; Hoffman P C
A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer.
Clinical lung cancer 2000;2(2):128-32.
2000: Innocenti F; Stadler W M; Iyer L; Ramírez J; Vokes E E; Ratain M J
Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3400-5.
2000: Lad T; Rosen F; Sciortino D; Brockstein B; Keubler J P; Arietta R; Vokes E
Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer.
Investigational new drugs 2000;18(3):261-3.
2000: Vokes E E; Haraf D J; Kies M S
The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
Seminars in oncology 2000;27(4 Suppl 8):34-8.
2000: Stenson K M; Haraf D J; Pelzer H; Recant W; Kies M S; Weichselbaum R R; Vokes E E
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
Archives of otolaryngology--head & neck surgery 2000;126(8):950-6.
2000: Brockstein B; Haraf D J; Stenson K; Sulzen L; Witt M E; Weichselbaum R W; Vokes E E
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):721-8.
2000: Fossella F V; DeVore R; Kerr R N; Crawford J; Natale R R; Dunphy F; Kalman L; Miller V; Lee J S; Moore M; Gandara D; Karp D; Vokes E; Kris M; Kim Y; Gamza F; Hammershaimb L
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(12):2354-62.
2000: Ryan C W; Shulman K L; Richards J M; Kugler J W; Sosman J A; Ansari R H; Vokes E E; Vogelzang N J
CI-980 in advanced melanoma and hormone refractory prostate cancer.
Investigational new drugs 2000;18(2):187-91.
2000: Vokes E E; Kies M S; Haraf D J; Stenson K; List M; Humerickhouse R; Dolan M E; Pelzer H; Sulzen L; Witt M E; Hsieh Y C; Mittal B B; Weichselbaum R R
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1652-61.
2000: Stenson K M; MacCracken E; List M; Haraf D J; Brockstein B; Weichselbaum R; Vokes E E
Swallowing function in patients with head and neck cancer prior to treatment.
Archives of otolaryngology--head & neck surgery 2000;126(3):371-7.
2000: Hoffman P C; Mauer A M; Vokes E E
Lung cancer.
Lancet 2000;355(9202):479-85.
2000: Kornblau S; Benson A B; Catalano R; Champlin R E; Engelking C; Field M; Ippoliti C; Lazarus H M; Mitchell E; Rubin J; Stiff P J; Vokes E; Wadler S
Management of cancer treatment-related diarrhea. Issues and therapeutic strategies.
Journal of pain and symptom management 2000;19(2):118-29.
2000: List M A; Stracks J; Colangelo L; Butler P; Ganzenko N; Lundy D; Sullivan P; Haraf D; Kies M; Goodwin W; Vokes E E
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):877-84.
2000: Ferguson M K; Wang J; Hoffman P C; Haraf D J; Olak J; Masters G A; Vokes E E
Sex-associated differences in survival of patients undergoing resection for lung cancer.
The Annals of thoracic surgery 2000;69(1):245-9; discussion 249-50.
2000: Stadler W M; Vogelzang N J; Amato R; Sosman J; Taber D; Liebowitz D; Vokes E E
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):371-5.
1999: Vokes E E; Green M R
Current strategies for locoregionally advanced unresectable non-small cell lung cancer.
Seminars in oncology 1999;26(5 Suppl 15):40-3.
1999: Gordon G S; Vokes E E
Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies.
Oncology (Williston Park, N.Y.) 1999;13(8):1075-88; discussion 1088, 1091-4.
1999: Vokes E E; Goh B C; Bertucci D; Vogelzang N J; Mani S; Ratain M J
A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors.
Cancer 1999;86(3):528-32.
1999: Lee M M; Vokes E E; Rosen A; Witt M E; Weichselbaum R R; Haraf D J
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
The cancer journal from Scientific American 1999;5(4):219-23.
1999: Minami H; Lad T E; Nicholas M K; Vokes E E; Ratain M J
Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1325-30.
1999: Lee J S; Jani A B; Pelizzari C A; Haraf D J; Vokes E E; Weichselbaum R R; Chen G T
Volumetric visualization of head and neck CT data for treatment planning.
International journal of radiation oncology, biology, physics 1999;44(3):693-703.
1999: Vokes E E; Haraf D J; Brockstein B E; Weichselbaum R R
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
Seminars in radiation oncology 1999;9(2 Suppl 1):70-6.
1999: List M A; Siston A; Haraf D; Schumm P; Kies M; Stenson K; Vokes E E
Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1020-8.
1999: Haraf D J; Kies M; Rademaker A W; Stenson K; Mittal B; Pelzer H; Wenig B; Witt M E; Sulzen L; Weichselbaum R R; Vokes E E
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):638-44.
1999: Humerickhouse R A; Dolan M E; Haraf D J; Brockstein B; Stenson K; Kies M; Sulzen L; Ratain M J; Vokes E E
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):291-8.
1999: Pena J C; Thompson C B; Recant W; Vokes E E; Rudin C M
Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck.
Cancer 1999;85(1):164-70.
1999: Mani S; Sciortino D; Samuels B; Arrietta R; Schilsky R L; Vokes E E; Benner S
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
Investigational new drugs 1999;17(1):97-101.
1999: DeMario M D; Ratain M J; Vogelzang N J; Mani S; Vokes E E; Fleming G F; Melton K; Johnson S; Benner S; Lebwohl D
A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days.
Cancer chemotherapy and pharmacology 1999;43(5):385-8.
1998: Vokes E E; Ansari R H; Masters G A; Hoffman P C; Klepsch A; Ratain M J; Sciortino D F; Lad T E; Krauss S; Fishkin P A; Golomb H M
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1085-90.
1998: Vokes E E; Brockstein B E; Humerickhouse R; Haraf D J
Oral 5-FU alternatives for the treatment of head and neck cancer.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 7):35-8.
1998: Mani S; Kugler J W; Sciortino D F; Garcia J C; Ansari R H; Humerickhouse R; Michelassi F; Posner M C; Shulman K L; Schilsky R L; List M; Vokes E E; Benner S
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1035-7.
1998: Wadler S; Benson A B; Engelking C; Catalano R; Field M; Kornblau S M; Mitchell E; Rubin J; Trotta P; Vokes E
Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3169-78.
1998: Vokes E E; Gregor A; Turrisi A T
Gemcitabine and radiation therapy for non-small cell lung cancer.
Seminars in oncology 1998;25(4 Suppl 9):66-9.
1998: Kies M S; Haraf D J; Athanasiadis I; Kozloff M; Mittal B; Pelzer H; Rademaker A W; Wenig B; Weichselbaum R R; Vokes E E
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2715-21.
1998: Vokes E E; Mauer A M
Multimodality therapy for esophageal cancer: an emerging role.
The cancer journal from Scientific American 1998;4(4):226-9.
1998: Vokes E E; Mauer A M; Hoffman P C; Haraf D J
Combined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy.
Seminars in oncology 1998;25(3 Suppl 8):28-32.
1998: Masters G A; Mauer A M; Hoffman P C; Wyka D; Samuels B L; Krauss S A; Watson S; Golomb H; Vokes E E
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(6):677-80.
1998: Hoffman P C; Haraf D J; Ferguson M K; Drinkard L C; Vokes E E
Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(6):647-51.
1998: Masters G A; Haraf D J; Hoffman P C; Drinkard L C; Krauss S A; Ferguson M K; Olak J; Samuels B L; Golomb H M; Vokes E E
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2157-63.
1998: Fleming G F; Kugler J W; Hoffman P C; Ansari R; Bitran J D; Klepsch A; Malone D; Fasanmade A A; Ratain M J; Vokes E E
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2032-7.
1998: Vogelzang N J; Mani S; Schilsky R L; Ansari R H; Taber D; Rhinehart S N; Garcia J C; Meyer S C; Mick R; Brockstein B E; Stadler W M; Ratain M J; Vokes E E
Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(4):929-34.
1998: Toljanic J A; Ali M; Haraf D J; Vokes E E; Moran W J; Graham L
Osteoradionecrosis of the jaws as a risk factor in radiotherapy: a report of an eight-year retrospective review.
Oncology reports 1998;5(2):345-9.
1998: Vokes E E; Masters G A; Mauer A M; Hoffman P C; Watson S; Golomb H M
Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
Seminars in oncology 1998;25(1 Suppl 2):19-22.
1998: Masters G A; Hoffman P C; Drinkard L C; Samuels B L; Golomb H M; Vokes E E
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
Seminars in oncology 1998;25(1 Suppl 2):8-14.
1998: Brockstein B; Haraf D J; Stenson K; Fasanmade A; Stupp R; Glisson B; Lippman S M; Ratain M J; Sulzen L; Klepsch A; Weichselbaum R R; Vokes E E
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):735-44.
1998: Vokes E E; Figlin R; Hochster H; Lotze M; Rybak M E
A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer.
The cancer journal from Scientific American 1998;4(1):46-51.
1998: Mauer A M; Masters G A; Haraf D J; Hoffman P C; Watson S M; Golomb H M; Vokes E E
Phase I study of docetaxel with concomitant thoracic radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):159-64.
1998: Mani S; Schiano T; Garcia J C; Ansari R H; Samuels B; Sciortino D F; Tembe S; Shulman K L; Baker A; Benner S E; Vokes E E
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma.
Investigational new drugs 1998;16(3):279-83.
1998: Mani S; Kugler J W; Knost J A; Sciortino D F; Gibbons J; Garcia J C; Ansari R H; Schilsky R L; Vokes E E
Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer.
Investigational new drugs 1998;16(3):275-8.
1998: Vokes E E; Green M R
Clinical studies in non-small cell lung cancer: the CALGB experience.
Cancer investigation 1998;16(2):72-9.
1997: Portugal L G; Goldenberg J D; Wenig B L; Ferrer K T; Nodzenski E; Sabnani J B; Javier C; Weichselbaum R R; Vokes E E
Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.
Archives of otolaryngology--head & neck surgery 1997;123(11):1230-4.
1997: Vokes E E; Liebowitz D N; Weichselbaum R R
Nasopharyngeal carcinoma.
Lancet 1997;350(9084):1087-91.
1997: Vokes E E
Combined-modality therapy of head and neck cancer.
Oncology (Williston Park, N.Y.) 1997;11(9 Suppl 9):27-30.
1997: Vokes E E; Masters G A; Mauer A M; Haraf D J; Hoffman P C; Golomb H M
Clinical studies of docetaxel (Taxotere) and concomitant chest therapy.
Seminars in oncology 1997;24(4 Suppl 14):S14-26-S14-29.
1997: Vokes E E; Mauer A M; Hoffman P C; Masters G; Watson S; Golomb H M
Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 12):S12-67-S12-69.
1997: Vokes E E
CHART for non-small-cell lung cancer--promises and limitations.
Lancet 1997;350(9072):156-7.
1997: Vokes E E; Leopold K A; Herndon J; Green M R
Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
Seminars in oncology 1997;24(3 Suppl 8):S8-42-S8-45.
1997: Vokes E E
Combined modality therapy of solid tumours.
Lancet 1997;349 Suppl 2():SII4-6.
1997: List M A; Mumby P; Haraf D; Siston A; Mick R; MacCracken E; Vokes E
Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1997;6(3):274-84.
1997: Gupta E; Mick R; Ramirez J; Wang X; Lestingi T M; Vokes E E; Ratain M J
Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1502-10.
1997: Masters G A; Hoffman P C; Hsieh A; Drinkard L C; Mick R; Samuels B L; Guaspari A; Golomb H M; Vokes E E
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):884-92.
1997: Haraf D J; Stenson K; List M; Witt M E; Weichselbaum R R; Vokes E E
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Seminars in oncology 1997;24(1 Suppl 2):S2-68-S2-71.
1997: Athanasiadis I; Taylor S; Vokes E E; Pelzer H J; Rademaker A; Mittal B B; Ganzenko N; Blough R; Lester E P; Kies M S
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Cancer 1997;79(3):588-94.
1997: Soliven B; Dhand U K; Kobayashi K; Arora R; Martin B; Petersen M V; Janisch L; Vogelzang N J; Vokes E E; Ratain M J
Evaluation of neuropathy in patients on suramin treatment.
Muscle & nerve 1997;20(1):83-91.
1997: Fleming G F; O'Brien S M; Hoffman P C; Vokes E E; Vogelzang N J; Schilsky R L; Waggoner S E; Ratain M J
Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin.
Cancer chemotherapy and pharmacology 1997;39(3):227-32.
1996: Kobayashi K; Weiss R E; Vogelzang N J; Vokes E E; Janisch L; Ratain M J
Mineralocorticoid insufficiency due to suramin therapy.
Cancer 1996;78(11):2411-20.
1996: Vokes E E
Progress in unresectable stage III non-small cell lung cancer.
The cancer journal from Scientific American 1996;2(6):304-6.
1996: Haraf D J; Weichselbaum R R; Vokes E E
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(9):913-8.
1996: Sweeney P J; Haraf D J; Recant W; Kaplan E L; Vokes E E
Anaplastic carcinoma of the thyroid.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(7):739-44.
1996: Kobayashi K; Vokes E E; Vogelzang N J; Janisch L; Soliven B; Ratain M J
Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2622-3.
1996: Mick R; Gupta E; Vokes E E; Ratain M J
Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2012-9.
1996: Vokes E E; Hoffman P C; Masters G A; Golomb H M; Drinkard L C; Krauss S A
Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
Seminars in oncology 1996;23(3 Suppl 7):15-8.
1996: Hoffman P C; Masters G A; Drinkard L C; Krauss S A; Samuels B L; Golomb H M; Vokes E E
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
Seminars in oncology 1996;23(3 Suppl 6):11-5.
1996: Fleming G F; Janisch L; Vogelzang N J; Vokes E E; Ratain M J
Phase I study of escalating doses of mitoxantrone and paclitaxel with granulocyte-macrophage colony stimulating factor support.
Cancer 1996;77(11):2308-12.
1996: List M A; D'Antonio L L; Cella D F; Siston A; Mumby P; Haraf D; Vokes E
The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.
Cancer 1996;77(11):2294-301.
1996: Vokes E E; Mick R; Kies M S; Dolan M E; Malone D; Athanasiadis I; Haraf D J; Kozloff M; Weichselbaum R R; Ratain M J
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1663-71.
1996: Haraf D J; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes E E; Weichselbaum R R
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):755-62.
1996: Vokes E E; Haraf D J; Masters G A; Hoffman P C; Drinkard L C; Ferguson M; Olak J; Watson S; Golomb H M
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Seminars in oncology 1996;23(2 Suppl 5):48-52.
1996: Masters G A; Hoffman P C; Drinkard L C; Watson S; Samuels B L; Golomb H M; Vokes E E
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Seminars in oncology 1996;23(2 Suppl 5):11-8.
1996: Hoffman P C; Masters G A; Drinkard L C; Krauss S A; Samuels B L; Golomb H M; Vokes E E
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):314-6.
1996: Mick R; Vokes E E; Lestingi T M; Gray-Stern W; Fleming G F; Schilsky R L; Ratain M J
Etoposide combined with interferon alfa-2b: novel exploitation of established etoposide pharmacokinetics and pharmacodynamics.
Clinical pharmacology and therapeutics 1996;59(3):349-59.
1996: Vokes E E; Athanasiadis I
Chemotherapy of squamous cell carcinoma of head and neck: the future is now.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):15-29.
1996: Fleming G F; Vokes E E; Buse J B; Mick R; Dushay J; Levitan D; Dolan M E
Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitus.
Cancer chemotherapy and pharmacology 1996;37(6):569-73.
1995: Masters G A; Drinkard L C; Hoffman P C; Lane N; Watson S; Samuels B L; Bitran J D; Golomb H M; Vokes E E
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
The cancer journal from Scientific American 1995;1(4):288-94.
1995: Vokes E E; Haraf D J; Stenson K; Stupp R; Malone D; Levin J; Weichselbaum R R
The role of paclitaxel in the treatment of head and neck cancer.
Seminars in oncology 1995;22(5 Suppl 12):8-12.
1995: Hallahan D E; Vokes E E; Rubin S J; O'Brien S; Samuels B; Vijaykumar S; Kufe D W; Phillips R; Weichselbaum R R
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
The cancer journal from Scientific American 1995;1(3):204-9.
1995: Vokes E E; Liebowitz D
The standard to come: systemic therapies for systemic disease.
The cancer journal from Scientific American 1995;1(3):184-6.
1995: Kobayashi K; Vokes E E; Vogelzang N J; Janish L; Soliven B; Ratain M J
Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2196-207.
1995: Hoffman P C; Krauss S A; Drinkard L C; Masters G A; Samuels B L; Bitran J D; Golomb H M; Watson S; Vokes E E
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
Seminars in oncology 1995;22(4 Suppl 9):38-41.
1995: Vokes E E
Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 1995;9(6):565-74, 577; discussion 577-8, 581-.
1995: Vokes E E; Stupp R; Haraf D; Moran W; Malone D; Wenig B; Sweeney P; Weichselbaum R R
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
Seminars in oncology 1995;22(3 Suppl 6):47-52.
1995: Vokes E E; Kies M; Haraf D J; Mick R; Moran W J; Kozloff M; Mittal B; Pelzer H; Wenig B; Panje W
Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):876-83.
1995: Drinkard L C; Hoffman P C; Samuels B L; Watson S; Bitran J D; Golomb H M; Vokes E E
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
Seminars in oncology 1995;22(2 Suppl 5):30-7; discussion 41-4.
1995: Ferguson M K; Reeder L B; Hoffman P C; Haraf D J; Drinkard L C; Vokes E E
Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction.
Annals of surgical oncology 1995;2(2):101-6.
1995: Stupp R; Vokes E E
[Advances in the treatment of head and neck tumors. 2. Radiochemotherapy]
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(3):140-8.
1995: Vokes E E; Rosenberg R K; Jahanzeb M; Craig J B; Gralla R J; Belani C P; Jones S E; Bigley J W; Hohneker J A
Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):637-44.
1995: Stupp R; Vokes E E
[Advances in the treatment of head and neck tumors. I. Chemotherapy]
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(1):12-7.
1995: Vokes E E
Considerations for the combined use of chemotherapy and radiation therapy.
The Journal of infusional chemotherapy 1995;5(4):179-81.
1995: Rosen F; Vokes E E; Lad T; Kies M; Wade J; Kilton L J; Blough R; French S; Mullane M; Benson A B
Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.
Investigational new drugs 1995;13(3):249-52.
1995: Stupp R; Vokes E E
5-fluorouracil plus radiation for head and neck cancer.
The Journal of infusional chemotherapy 1995;5(2):55-60.
1995: Haraf D J; Weichselbaum R R; Vokes E E
Timing and sequencing of chemoradiotherapy.
Cancer treatment and research 1995;74():173-98.
1995: Weichselbaum R R; Beckett M A; Vokes E E; Brachman D G; Haraf D; Hallahan D; Kufe D
Cellular and molecular mechanisms of radioresistance.
Cancer treatment and research 1995;74():131-40.
1995: Krishnasamy S; Vokes E E; Dohrmann G J; Mick R; Garcia J C; Kolker J D; Wollmann R L; Hekmatpanah J; Weichselbaum R R
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.
Cancer investigation 1995;13(5):453-9.
1995: Vokes E E; Haraf D J; Drinkard L C; Hoffman P C; Ferguson M K; Vogelzang N J; Watson S; Lane N J; Golomb H M
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Cancer chemotherapy and pharmacology 1995;35(4):304-12.
1994: Vokes E E
The promise of biochemical modulation in combined modality therapy.
Seminars in oncology 1994;21(6 Suppl 14):29-33.
1994: Vokes E E; Haraf D J; Mick R; McEvilly J M; Weichselbaum R R
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2351-9.
1994: Vokes E E; Drinkard L C; Samuels B L; Hoffman P C; Watson S; Bitran J D; Haraf D J; Ferguson M F; Golomb H M
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Seminars in oncology 1994;21(5 Suppl 10):79-83; discussion 83-4.
1994: Vokes E E; Rosenberg R; Jahanzeb M; Craig J; Gralla R; Belani C; Jones S; Bigley J; Hohneker J
Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.
Seminars in oncology 1994;21(5 Suppl 10):35-8; discussion 38-41.
1994: Gupta E; Lestingi T M; Mick R; Ramirez J; Vokes E E; Ratain M J
Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.
Cancer research 1994;54(14):3723-5.
1994: Kobayashi K; Vogelzang N J; O'Brien S M; Schilsky R L; Vokes E E; Ratain M J
A phase I study of intermittent infusion cladribine in patients with solid tumors.
Cancer 1994;74(1):168-73.
1994: Stupp R; Weichselbaum R R; Vokes E E
Combined modality therapy of head and neck cancer.
Seminars in oncology 1994;21(3):349-58.
1994: Sweeney P J; Haraf D J; Vokes E E; Dougherty M; Weichselbaum R R
Radiation therapy in head and neck cancer: indications and limitations.
Seminars in oncology 1994;21(3):296-303.
1994: Skoog L A; Vokes E E
Chemotherapy, biologics, and chemoprevention as systemic therapies for head and neck cancer.
Current opinion in oncology 1994;6(3):277-84.
1994: Wong W W; Mick R; Haraf D J; Weichselbaum R R; Vokes E E
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
International journal of radiation oncology, biology, physics 1994;29(1):153-62.
1994: Vokes E E; Haraf D J; Hoffman P C; Bitran J D; Ferguson M K; Golomb H M
Concomitant chemoradiotherapy for non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S253-61.
1993: Vokes E E; Dolan M E; Krishnasamy S; Mick R; Ratain M J; Berezin F; Brachman D; Whitman G; Schilsky R L; Charette J
5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(7):591-5.
1993: Brachman D G; Beckett M; Graves D; Haraf D; Vokes E; Weichselbaum R R
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
Cancer research 1993;53(16):3667-9.
1993: Rosen A; Vokes E E; Scher N; Haraf D; Weichselbaum R R; Panje W R
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
Archives of otolaryngology--head & neck surgery 1993;119(7):743-6.
1993: Vokes E E
Interactions of chemotherapy and radiation.
Seminars in oncology 1993;20(1):70-9.
1993: Vokes E E; Ratain M J; Mick R; McEvilly J M; Haraf D; Kozloff M; Hamasaki V; Weichselbaum R R; Panje W R; Wenig B
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):360-8.
1993: Vokes E E; O'Brien S M; Vogelzang N J; Schilsky R L; Ratain M J
Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study.
Cancer chemotherapy and pharmacology 1993;32(5):347-52.
1993: Vokes E E; Haraf D J; Hoffman P C
Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study.
Cancer chemotherapy and pharmacology 1993;33(3):203-9.
1993: Vokes E E
Fluorouracil modulation in head and neck cancer.
Advances in experimental medicine and biology 1993;339():197-208; discussion 219-21.
1992: Kobayashi K; Vokes E E; Stefansson K; Janisch L; Vogelzang N J; Berezin F; Ratain M J
Suramin: is adaptive control necessary?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1984-5; author reply 1985-6.
1992: Vokes E E; Lyss A P; Herndon J E; Cooper B; Perry M C; Vinciguerra V; Mason-Coughlin K; Green M R
Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):727-32.
1992: Brachman D G; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum R R
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
Cancer research 1992;52(17):4832-6.
1992: Vokes E E; Haraf D J; Weichselbaum R R; McEvilly J M; Sutton H G; Panje W R
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
Seminars in oncology 1992;19(4 Suppl 11):47-56.
1992: Weichselbaum R R; Beckett M A; Hallahan D E; Kufe D W; Vokes E E
Molecular targets to overcome radioresistance.
Seminars in oncology 1992;19(4 Suppl 11):14-20.
1992: Haraf D J; Devine S; Ihde D C; Vokes E E
The evolving role of systemic therapy in carcinoma of the lung.
Seminars in oncology 1992;19(4 Suppl 11):72-87.
1992: Schilsky R L; Ratain M J; Vokes E E; Vogelzang N J; Anderson J; Peterson B A
Laboratory and clinical studies of biochemical modulation by hydroxyurea.
Seminars in oncology 1992;19(3 Suppl 9):84-9.
1992: Vokes E E; Haraf D J; Panje W R; Schilsky R L; Weichselbaum R R
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
Seminars in oncology 1992;19(3 Suppl 9):53-8.
1992: Haraf D J; Vokes E E; Weichselbaum R R; Panje W R
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
The Laryngoscope 1992;102(6):630-6.
1992: Hamasaki V K; Vokes E E
Chemotherapy in head and neck cancer.
Current opinion in oncology 1992;4(3):504-11.
1992: Vokes E E; Weichselbaum R R; Mick R; McEvilly J M; Haraf D J; Panje W R
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Journal of the National Cancer Institute 1992;84(11):877-82.
1992: Vokes E E; Haraf D J; McEvilly J M; Mick R; Kozloff M F; Goldman M D; Moran W J; Clendeninn N J; Collier M A; Weichselbaum R R
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(1):79-81.
1992: Vokes E E; Moormeier J A; Ratain M J; Egorin M J; Haraf D J; Mick R; Weichselbaum R R
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
Cancer chemotherapy and pharmacology 1992;29(3):178-84.
1992: Vokes E E; Beckett M; Karrison T; Weichselbaum R R
The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.
Oncology 1992;49(6):454-60.
1992: Stadler W M; Vogelzang N J; Vokes E E; Charette J; Whitman G
Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer.
Cancer chemotherapy and pharmacology 1992;31(3):213-6.
1991: Devine S M; Vokes E E; Weichselbaum R R
Chemotherapeutic and biologic radiation enhancement.
Current opinion in oncology 1991;3(6):1087-95.
1991: Haraf D J; Vokes E E; Panje W R; Weichselbaum R R
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
American journal of clinical oncology 1991;14(5):419-26.
1991: Smith D H; Goldwasser E; Vokes E E
Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy.
Cancer 1991;68(5):1101-5.
1991: Vokes E E; Mick R; Lester E P; Panje W R; Weichselbaum R R
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1376-84.
1991: Vokes E E; Awan A M; Weichselbaum R R
Radiotherapy with concomitant chemotherapy for head and neck cancer.
Hematology/oncology clinics of North America 1991;5(4):753-67.
1991: Awan A M; Vokes E E; Weichselbaum R R
Recent advances in radiation therapy for head and neck cancer.
Hematology/oncology clinics of North America 1991;5(4):635-55.
1991: Mick R; Vokes E E; Weichselbaum R R; Panje W R
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1991;105(1):62-73.
1991: Vokes E E
Chemotherapy and integrated treatment approaches in head and neck cancer.
Current opinion in oncology 1991;3(3):529-34.
1991: Vokes E E; Dimery I W; Jacobs C D; Karp D; Molina A; Collier M A; Eble M L; Clendeninn N J
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer.
Cancer 1991;67(9):2253-7.
1991: Gradishar W; Vokes E; Schilsky R; Weichselbaum R; Panje W
Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience.
Medical and pediatric oncology 1991;19(1):8-15.
1991: Fleming G F; Vokes E E; McEvilly J M; Janisch L; Francher D; Smaldone L
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.
Cancer chemotherapy and pharmacology 1991;28(3):226-7.
1991: Vokes E E; Raschko J W; Vogelzang N J; Warfield E E; Ratain M J; Doroshow J H; Schilsky R L
Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study.
Cancer chemotherapy and pharmacology 1991;28(1):69-73.
1990: Vokes E E
Sequential combined modality therapy for stage III non-small cell lung cancer.
Hematology/oncology clinics of North America 1990;4(6):1133-42.
1990: Bitran J D; Vokes E E
Chemotherapy for stage IV non-small cell lung cancer.
Hematology/oncology clinics of North America 1990;4(6):1159-68.
1990: Gradishar W J; Vokes E E; Ni K; Panje W R
Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report.
Cancer 1990;66(9):1914-8.
1990: Gradishar W J; Vokes E E
5-Fluorouracil cardiotoxicity: a critical review.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(6):409-14.
1990: Vokes E E; Vijayakumar S; Hoffman P C; Ferguson M K; Bitran J D; Krishnasamy S; Jacobs R; Golomb H M
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer.
Cancer 1990;66(3):437-42.
1990: Vokes E E; Panje W R; Mick R; Kozloff M F; Moran W J; Sutton H G; Goldman M D; Tybor A G; Weichselbaum R R
A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer.
Cancer 1990;66(2):206-13.
1990: Vokes E E; Weichselbaum R R
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):911-34.
1990: Vokes E E; Schilsky R L; Weichselbaum R R; Kozloff M F; Panje W R
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):241-7.
1990: Gradishar W J; Vokes E E; Kies M S
Phase II trial of etoposide and doxorubicin in advanced head and neck cancer.
Medical and pediatric oncology 1990;18(6):487-90.
1989: Hallahan D E; Farah R; Vokes E E; Bitran J D; Ultmann J E; Golomb H M; Weichselbaum R R
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone.
International journal of radiation oncology, biology, physics 1989;17(4):767-71.
1989: Weichselbaum R R; Dunphy E J; Beckett M A; Tybor A G; Moran W J; Goldman M E; Vokes E E; Panje W R
Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines.
Head & neck 1989;11(5):437-42.
1989: Runge-Morris M A; Kies M S; Vokes E; Blough R; Weidner L; Knop R; Rowland K
Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study.
Investigational new drugs 1989;7(2-3):269-73.
1989: Weichselbaum R R; Beckett M A; Vijayakumar S; Ahmed-Swan S; Dritschilo A; Schwartz J L; Moran W J; Goldman M E; Tybor A G; Vokes E E
Radioresistant tumor cell lines derived from head and neck radiation failures.
Head & neck 1989;11(4):343-8.
1989: Vokes E E; Moran W J; Mick R; Weichselbaum R R; Panje W R
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(7):838-45.
1989: Vokes E E; Bitran J D; Hoffman P C; Ferguson M K; Weichselbaum R R; Golomb H M
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
Chest 1989;96(1):110-3.
1989: Vokes E E; Panje W R; Schilsky R L; Mick R; Awan A M; Moran W J; Goldman M D; Tybor A G; Weichselbaum R R
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(6):761-8.
1989: Vokes E E; Golomb H M; Samuels B L; Brownstein B H
Heat shock proteins in normal and leukemic blood cells.
Journal of interferon research 1989;9(2):195-204.
1989: Panje W R; Dohrmann G J; Pitcock J K; Scher N; Weichselbaum R R; Sutton H G; Vokes E; Moss J
The transfacial approach for combined anterior craniofacial tumor ablation.
Archives of otolaryngology--head & neck surgery 1989;115(3):301-7.
1989: Vokes E E; Schilsky R L; Weichselbaum R R; Guaspari A; Guarnieri C M; Whaling S M; Panje W R
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Cancer 1989;63(6 Suppl):1048-53.
1989: Schilsky R L; Choi K E; Vokes E E; Guaspari A; Guarnieri C; Whaling S; Liebner M A
Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
Cancer 1989;63(6 Suppl):1018-21.
1989: Vokes E E; Schilsky R L; Choi K E; Magid D M; Guarnieri C M; Whaling S M; Ratain M J; Weichselbaum R R; Panje W R
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
Cancer 1989;63(1):30-6.
1989: Magid D M; Vokes E E; Schilsky R L; Guarnieri C M; Whaling S M; Weichselbaum R R; Panje W R
A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects.
Selective cancer therapeutics 1989;5(3):137-45.
1988: Gruber B; Moran W J; Vokes E E; Dobleman T J; Shaw G Y; Guarnieri C M; Panje W R
Implantable venous access device: use in patients with advanced head and neck cancer.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1988;99(6):578-83.
1988: Vokes E E; Choi K E; Schilsky R L; Moran W J; Guarnieri C M; Weichselbaum R R; Panje W R
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):618-26.
1988: Vokes E E; Panje W R; Weichselbaum R R; Schilsky R L; Moran W J; Awan A M; Guarnieri C M
Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1988;98(4):295-8.
1988: Vokes E E; Moran W J; Awan A M; Schilsky R L; Goldman M; Sutton H G; Weichselbaum R R; Panje W R
Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer.
NCI monographs : a publication of the National Cancer Institute 1988;(6):353-6.
1985: Vokes E E; Ultmann J E; Golomb H M; Gaynor E R; Ferguson D J; Griem M L; Oleske D
Long-term survival of patients with localized diffuse histiocytic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(10):1309-17.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Everett Vokes

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Everett Vokes (preview)

All Publications